The GLP-1 market brings those two propositions into particularly sharp tension
Taking it at the same time each week reduces the variability in plasma levels that can affect both efficacy and side effects
and actually SARS-CoV-2 causing COVID-19, all are characterized by persistent inflammation, continuous production of reactive oxygen/nitrogen species and oxidative stress that predominate over the antioxidant defenses (GSH and free radical scavenger enzymes) resulting in cell/tissue/organ aging associated with early (premature) chronic inflammation/inflammaging. We propose that, although inflammaging was introduced for the aging process (276289), it could also apply to early (premature) tissue and organ aging associated with cell and tissue damage caused by excessive oxidative stress and lack of adequate antioxidant defenses, especially low GSH levels, in younger individuals
As a general guideline, some individuals might start with a series of weekly sessions and then taper down to less frequent sessions once they start experiencing the desired effects, although they are safe to have every day
Expect more lawsuits to be filed in the coming weeks and months as this litigation grows
SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin) increase urinary glucose excretion, creating a glucose-rich environment in the genitourinary tract that promotes fungal overgrowth